Julie R. Gralow
M.D., University Southern California, 1988.
B.S., Stanford University, 1981.
Julie Gralow majored in biologic sciences at Stanford University before attending medical school at the University of Southern California. She completed a residency in internal medicine at Harvard Medical School's Brigham and Women's Hospital, followed by a medical oncology fellowship at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center, two institutions at which she currently holds joint faculty appointments.
Specializing in breast cancer, Dr. Gralow is the co-Chair of the Southwest Oncology Group's Breast Cancer Committee. She is the Principle Investigator on numerous local and national clinical trials related to breast cancer treatment, prevention, and survivorship. Her area of research specialization is the relationship between breast cancer and the bone, and she currently leads a 4,500 patient Phase III North American Breast Intergroup group trial investigating the role of bisphosphonates in preventing bone metastases.
Dr. Gralow is committed to improving quality of life for breast cancer patients through education, exercise and diet, and to promoting breast cancer awareness in the community. Dr. Gralow is the Medical Director and Team Physician for 'Team Survivor Northwest,' a group of female cancer survivors dedicated to improving their health through fitness and exercise.
She is board-certified in in medical oncology, and is a member of the American Society of Clinical Oncology, Southwest Oncology Group, American Association for Cancer Research, Puget Sound Oncology Consortium, the American Society of Breast Disease, and Washington State Medical Oncology Society.
Dr. Gralow is Co-Chair of the Breast Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. She is an elected member of the American Society of Clinical Oncology's (ASCO) Nominating Committee, was Chair for ASCO's Cancer Communications Committee in 2008-09, and served as Co-Chair of an NCI State of the Science Conference on Preoperative Therapy in Breast Cancer in 2007. She has served as a Board Member of the American Society of Breast Disease, and directs the American Cancer Society/UW Medical Student Summer Research Fellowship Program.
Vice-Chair, Southwest Oncology Group (SWOG) Breast Cancer Committee 2000-present
Executive Committee Member, SWOG Committee on Special Populations/Survivorship 1995-present
Co-Chair, Breast Scientific Leadership Council Steering Committee, Coalition of Cancer Cooperative Groups 2005-present
American Society of Clinical Oncology
Member, ASCO Nominating Committee 2008-present
Member, ASCO Cancer Communications Committee 2005-present, Chair 2007/2008
Chair, ASCO Patient Communication Subcommittee 2005-2007
Member, ASCO Public Issues Committee 1999-2004; Co-Chair, 2000-2002
Member, ASCO Program Committee 2000
Member/Liaison, ASCO Health Services Research Committee 2000-2004
Member, Breast Health Advisory Panel, National Women's Health Resource Center 2005-present
Section Editor, Breast Cancer, UpToDate 2009-present
Editorial Board, Breast Diseases 2005-present
Editorial Board, The Breast Journal 2006-present
Editorial Board, Clinical Cancer Advances 2006-present
Editorial Advisor, Advances in Targeted Cancer Therapies, 2003-2007
Senator, University of Washington Faculty Senate 2002-2004
Fred Hutchinson Cancer Research Center Scientific Steering Committee 2002-present
Director, American Cancer Society/University of Washington Medical Student Summer Research Fellowship Program 1996-present
Member-at-Large, University of Washington Medical Staff Advisory Committee, 1998-2006
Co-Director, University of Washington Medical Center (UWMC) Patient and Family Education Committee 1996-2003
Member, University of Washington School of Medicine (UWSOM) Human Subjects Review Committee 1998 - 2000
Executive Committee Member, Seattle Breast Cancer Research Program 1995-present
Member, Puget Sound Oncology Consortium Breast Committee, 1994-present
Delegate, University of Washington Center for Women and Democracy, Cuba Mission 2003; Baltic Mission 2003; South Africa Mission 2004, Ukraine Mission 2005, China Mission 2006 + 2008, Morocco 2009
Consultant, Program for Appropriate Technology in Health (PATH), USAID Ukraine Breast Cancer Assistance Project 1997-2000
Member, Expedition Inspiration Breast Cancer Foundation Medical Advisory Board, 1999-present; Chair, 2001-2007
Professional Advisory Committee Member, Living Beyond Breast Cancer, 2005-present
Professional Advisory Board Member, Breast Cancer.org, 2004-present
Board Member, Puget Sound Affiliate of the Susan G. Komen Breast Cancer Foundation 1996-2001
Advisory Board Member, Puget Sound Affiliate of the Susan G. Komen Breast Cancer Foundation 2004-present
Physician Advisor, Marsha Rivkin Ovarian Cancer Center 1995-present
Member, Cancer Lifeline Medical Advisory Committee 1996-present; Chair, 1996-1998
Team Physician and Medical Director, Team Survivor Northwest 1995-present
(Reading, Writing, Speaking)
American Association for Cancer Research
American Society of Breast Disease
American Society of Clinical Oncology
Puget Sound Oncology Consortium
Southwest Oncology Group
Washington State Medical Oncology Society
Honors and Awards
2008, Fellow, American College of Physicians
2008, Statesman Award, American Society of Clinical Oncology
2008, Service Excellence Award, University of Washington Medical Center
2007, Certificate of Appreciation for Significant Contributions as Co-Chair of NCI's State of the Science Conference on Preoperative Therapy in Breast Cancer, National Cancer Institute (USA)
2007, Community Service Award to the "Finding Your Way To Wellness" Committee, Susan G. Komen Breast Cancer Foundation, Puget Sound Affiliate
2006, "Women of Valor" Award for Medicine and Health Care, Helen H. Jackson
2005, C.J. Taylor Outstanding Community Volunteer Award, Susan G. Komen Breast Cancer Foundation, Puget Sound Affiliate
2000, Outstanding Faculty Award, University of Washington Continuing Medical Education Department
2002-2009, Associate Professor, University of Washington, School of Medicine, Department of Medicine, Division of Medical Oncology
1999-2006, Assistant Member, Fred Hutchinson Cancer Research Center, Clinical Research Division, Breast
1998-2002, Director, University of Washington, School of Medicine, Women's Cancer Genetics & Risk Reduction Clinic
1998-2002, Director, University of Washington, School of Medicine, Cancer Center, Patient & Physician Education & Outreach
1998-2002, Assistant Professor, University of Washington, School of Medicine, Department of Medicine, Division of Medical Oncology
1994-1997, Acting Instructor, University of Washington, School of Medicine, Department of Medicine, Division of Medical Oncology
Current Treatment Options in Triple Negative Breast Cancer.. Breast disease. 32(1-2):99-112.. Submitted.
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2016.
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(7):701-8.. 2015.
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(1):58-64.. 2015.
Promoting Quality and Evidence-Based Care in Early-Stage Breast Cancer Follow-up.. Journal of the National Cancer Institute.. 2014.
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014.
Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014.
Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.. Pharmacoepidemiology and drug safety.. 2014.
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102.. Breast cancer research and treatment. 143(2):351-8.. 2014.
Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.. Breast cancer research and treatment. 143(3):541-50.. 2014.
Frequent antibiotic use and second breast cancer events.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1588-99.. 2013.
Supportive and palliative care for metastatic breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.. Breast (Edinburgh, Scotland). 22(5):616-27.. 2013.
Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.. Breast (Edinburgh, Scotland). 22(5):593-605.. 2013.
Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(17):2115-22.. 2013.
The importance of survivors and partners in improving breast cancer outcomes in Uganda.. Breast (Edinburgh, Scotland).. 2013.
Supplement use during an intergroup clinical trial for breast cancer (S0221).. Breast cancer research and treatment. 137(3):903-13.. 2013.
NCCN Task Force Report: Bone Health in Cancer Care.. Journal of the National Comprehensive Cancer Network : JNCCN. 11 Suppl 3:S1-S50.. 2013.
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis Journal of Comparative Effectiveness Research. 2(3):325-334.. 2013.
Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44.. 2012.
Hypnosis for symptom management in women with breast cancer: a pilot study.. The International journal of clinical and experimental hypnosis. 60(2):135-59.. 2012.